ArticleCancer research and treatment2022

The Role of Neutrophil-to-Lymphocyte Ratio in Predicting Pathological Response for Resectable Non-Small Cell Lung Cancer Treated with Neoadjuvant Chemotherapy Combined with PD-1 Checkpoint Inhibitors.

Xiaoyan Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.